title: Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T).
abstract: The purpose of our study was to evaluate the effects of 5 alpha-dihydrotestosterone (DHT) and hydroxyflutamide (HF), alone or in combination, on androgen receptor (AR) dynamics and on cellular growth in cultured breast cancer cells (EVSA-T). The incubation of cells with DHT increased the concentration of nuclear AR after 24 and 48 h. HF was also able to promote the nuclear accumulation of AR after 24 and 48 h of treatment. When HF-treated cells are incubated with DHT, the nuclear AR concentration is lower than that found in cells treated with DHT alone. We conclude that HF acts by increasing nuclear accumulation of receptor-antiandrogen complexes. Moreover, DHT stimulates cell growth while HF has an inhibitory effect. Thymidine incorporation in cells also increased after DHT treatment and decreased after HF incubation. The HF-induced inhibition of cell growth persisted both after renewal of the medium and after the addition of DHT to cultures. It may be hypothesized that either DHT is converted to inactive metabolites or that HF exerts a persistent inhibitory effect. In the latter case, the antiandrogen action of HF could be exerted by retention of high levels of antiandrogen in cells or by such a depressed protein synthesis that the renewal of growth is slower than the 48 h period studied.
authors.affiliation: Cattedra di Fisiopatologia Endocrina, ISMI, University of Genova, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Marugo
authors.forename: D
authors.initials: D
authors.lastname: Bernasconi
authors.forename: L
authors.initials: L
authors.lastname: Miglietta
authors.forename: L
authors.initials: L
authors.lastname: Fazzuoli
authors.forename: F
authors.initials: F
authors.lastname: Ravera
authors.forename: S
authors.initials: S
authors.lastname: Cassulo
authors.forename: G
authors.initials: G
authors.lastname: Giordano
mesh_terms: D000726:Androgen Antagonists / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D013196:Dihydrotestosterone / Q000494:pharmacology*; D005485:Flutamide / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D011944:Receptors, Androgen / Q000187:drug effects*; D014407:Tumor Cells, Cultured
chemical_list: D000726:Androgen Antagonists; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; C014290:hydroxyflutamide; D005485:Flutamide